chr10-78033903-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_033022.4(RPS24):c.2T>C(p.Met1?) variant causes a start lost, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_033022.4 start_lost, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPS24 | NM_033022.4 | c.2T>C | p.Met1? | start_lost, splice_region_variant | 1/6 | ENST00000372360.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPS24 | ENST00000372360.9 | c.2T>C | p.Met1? | start_lost, splice_region_variant | 1/6 | 1 | NM_033022.4 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Diamond-Blackfan anemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2016 | The p.M1? pathogenic mutation (also known as c.2T>C), located in coding exon 1 of the RPS24 gene, results from a T to C substitution at nucleotide position 2. This causes the loss of the initiation codon. Another alteration leading to initiation codon loss in RPS24, referred to as c.1A>G, was identified in a 26 year old female with Diamond-Blackfan anemia (DBA) who was transfusion dependent and had short stature and dysmorphic facial features. Functional studies of fibroblasts showed a reduction in protein and impaired cell growth in cells with this mutation (Badhai J et al, Biochim. Biophys. Acta 2009 Oct; 1792(10):1036-42). It was also reported in another DBA patient (Ghemlas I et al, J. Med. Genet. 2015 Sep; 52(9):575-84). In addition to the clinical data presented in the literature, since sequence variations that modify the initiation codon (ATG) are expected to cause a shift in the mRNA reading frame, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.